GLUCOVANCE Side Effects

5723723-0 | Blood Glucose Increased
on Apr 29, 2008 Female patient from UNITED STATES , weighting 222.0 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Glucovance dosage: 5/500 Bid Oral About Once A Month.

5708643-X | Liver Disorder, Pancreatitis, Renal Failure, Unevaluable Event
Patient was taking Glucovance (View Usage). Patient had the following side effects: liver disorder, pancreatitis, renal failure, unevaluable event on Apr 14, 2008 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 215.0 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: 1 Tablet Twice A Day Po. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5705381-4 | Cholelithiasis, Pancreatitis Acute, Renal Failure Acute, Respiratory Failure, Septic Shock
Adverse event was reported on Apr 03, 2008 by a Female patient taking Glucovance (View Usage) (Dosage: Dosing Strength = 5mg(meformin Hcl)/500mg(glibenclamide)) was diagnosed with hypertension and. Location: GERMANY , 69 years of age, After Glucovance was administered, patient had the following side effects: cholelithiasis, pancreatitis acute, renal failure acute, respiratory failure, septic shock. During the same period patient was treated with COMPETACT (Dosage Strength: 15 Mg(metformin Hcl)/850 Mg(pioglitazone Hcl)tablet.) (View Competact Review and Competact Label ), SPIROCTAN (Dosage Form - Capsule) (View Spiroctan Review and Spiroctan Label ), PHYSIOTENS (Dosage Form = Tablet) (View Physiotens Review and Physiotens Label ). Patient was hospitalized.

5704082-6 | Cytolytic Hepatitis
on Apr 09, 2008 Male patient from GERMANY , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Glucovance dosage: The Patient Was Treated With Metformin+glibenclamide (2.5 Mg/500) 5-dosage Forms /day Since Apr-07. Patient was hospitalized.


5683854-0 | Diabetic Nephropathy, Haemodialysis, Hypervolaemia, Lactic Acidosis, Lung Disorder, Renal Failure Acute
on Aug 06, 2007 Female patient from FRANCE , 61 years of age, was treated with Glucovance (View Usage). Patient had the following side effects: diabetic nephropathy, haemodialysis, hypervolaemia, lactic acidosis, lung disorder, renal failure acute. Glucovance dosage: . During the same period patient was treated with DETENSIEL (BISOPROLOL FUMARATE) (View Detensiel (bisoprolol Fumarate) Review and Detensiel (bisoprolol Fumarate) Label ), COAPROVEL (HYDROCHLOROTHIAZIDE, IRBESARTAN) (View Coaprovel (hydrochlorothiazide, Irbesartan) Review and Coaprovel (hydrochlorothiazide, Irbesartan) Label ), HYPERIUM (RILMENIDINE) (View Hyperium (rilmenidine) Review and Hyperium (rilmenidine) Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

5654568-8 | Pregnancy, Premature Labour
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: pregnancy (What is pregnancy?), premature labour on Mar 03, 2008 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with diabetes mellitus, blood cholesterol increased, multiple sclerosis (What is multiple sclerosis?), incontinence, fatigue and. Glucovance dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), PROVIGIL (View Provigil Review and Provigil Label ).

5642618-4 | Congenital Musculoskeletal Anomaly, Limb Malformation, Pulmonary Malformation, Rib Hypoplasia, Spine Malformation, Talipes
Adverse event was reported on Feb 25, 2008 by a Male patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, multiple sclerosis (What is multiple sclerosis?), pain (What is pain?), incontinence, fatigue, blood cholesterol increased and. Location: UNITED STATES , weighting 6.61 lb, Patient experienced the following unwanted or unexpected effects: congenital musculoskeletal anomaly, limb malformation, pulmonary malformation, rib hypoplasia, spine malformation, talipes. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DITROPAN (View Ditropan Review and Ditropan Label ), PROVIGIL (View Provigil Review and Provigil Label ), CRESTOR (View Crestor Review and Crestor Label ).

5642512-9 | No Therapeutic Response
on Feb 27, 2008 Male patient from UNITED STATES , 80 years of age, weighting 156.0 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: no therapeutic response. Glucovance dosage: 2.5/500 Bid Po.

5625791-3 | Somnolence
on Feb 13, 2008 Male patient from UNITED STATES , weighting 470.0 lb, was diagnosed with accidental exposure and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: somnolence. Glucovance dosage: Four Tablets Once Po. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LORCET (View Lorcet Review and Lorcet Label ). Patient was hospitalized.

5622844-0 | Headache
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?) on Feb 08, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 215.0 lb, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: 2.5/500 Tid Po. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CRESTOR (View Crestor Review and Crestor Label ), LASIX (View Lasix Review and Lasix Label ), NORVASC (View Norvasc Review and Norvasc Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), MULTIVIT. (View Multivit. Review and Multivit. Label ).

5588245-9 |
Adverse event was reported on Jan 10, 2008 by a Female patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 52 years of age, . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CELEXA (View Celexa Review and Celexa Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

5512681-X | Cytolytic Hepatitis
on Oct 29, 2007 Male patient from GERMANY , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: cytolytic hepatitis. Glucovance dosage: The Patient Was Treated With Metformin+glibenclamide (2.5 Mg/500) 5-dosage Forms /day Since Apr-07. Patient was hospitalized.

5489303-X | Lactic Acidosis, Productive Cough, Renal Failure Acute
on Oct 09, 2007 Female patient from FRANCE , 61 years of age, was diagnosed with type 1 diabetes mellitus, tachycardia, hypertension, hypercholesterolaemia and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, productive cough, renal failure acute. Glucovance dosage: . During the same period patient was treated with DETENSIEL (View Detensiel Review and Detensiel Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5477640-4 | Depression, Hypoglycaemic Seizure, Treatment Noncompliance
Patient was taking Glucovance (View Usage). Patient had the following side effects: depression (What is depression?), hypoglycaemic seizure, treatment noncompliance on Sep 20, 2007 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with type 2 diabetes mellitus and. Glucovance dosage: 2 Dosage Forms (1 Dosage Forms, 2in 1 D), Oral. During the same period patient was treated with MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), TRIVASTAL (PIRIBEDIL) (View Trivastal (piribedil) Review and Trivastal (piribedil) Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MODOPAR (LEVODOPA, BENSERAZIDE HYDROCHLORIDE) (View Modopar (levodopa, Benserazide Hydrochloride) Review and Modopar (levodopa, Benserazide Hydrochloride) Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5466671-6 | Cholestasis, Hepatocellular Damage
Adverse event was reported on Sep 24, 2007 by a Female patient taking Glucovance (View Usage) (Dosage: Several Years) . Location: UNITED STATES , 62 years of age, After Glucovance was administered, patient had the following side effects: cholestasis, hepatocellular damage. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), CENTRUM MULTIVITAMINS (View Centrum Multivitamins Review and Centrum Multivitamins Label ), ALEVE (View Aleve Review and Aleve Label ).

5465277-2 | Blood Glucose Increased, Hypokalaemia, Malaise
on Sep 20, 2007 Female patient from FRANCE , 73 years of age, was diagnosed with blood potassium abnormal, hypertension and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, hypokalaemia, malaise. Glucovance dosage: . During the same period patient was treated with IPERTEN (View Iperten Review and Iperten Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

5413639-1 | Blood Glucose Increased
on Jun 26, 2007 Male patient from UNITED STATES , weighting 220.5 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: blood glucose increased. Glucovance dosage: .

5413636-6 | Burning Sensation, Hypoaesthesia
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: burning sensation, hypoaesthesia on Jun 11, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CENTRUM (View Centrum Review and Centrum Label ).

5413635-4 | Diarrhoea, Hypoglycaemia
Adverse event was reported on May 31, 2007 by a Female patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 45 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, hypoglycaemia. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), JANUVIA (View Januvia Review and Januvia Label ), AMARYL (View Amaryl Review and Amaryl Label ), VYTORIN (View Vytorin Review and Vytorin Label ), ACTOS (View Actos Review and Actos Label ).

5413633-0 | Diarrhoea
on May 10, 2007 Female patient from UNITED STATES , 78 years of age, weighting 134.5 lb, was treated with Glucovance (View Usage). Patient had the following side effects: diarrhoea. Glucovance dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ).

5413632-9 | Blood Glucose Decreased
on Apr 24, 2007 Male patient from UNITED STATES , 70 years of age, weighting 194.0 lb, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: blood glucose decreased. Glucovance dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ).

5413631-7 | Blood Glucose Decreased, Somnolence
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, somnolence on Apr 20, 2007 from UNITED STATES Additional patient health information: Female patient , 83 years of age, weighting 200.6 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), ZOCOR (View Zocor Review and Zocor Label ).

5413628-7 | Blood Glucose Increased, International Normalised Ratio Decreased
Adverse event was reported on Apr 09, 2007 by a Male patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 57 years of age, weighting 260.1 lb, Patient had the following side effects: blood glucose increased, international normalised ratio decreased. During the same period patient was treated with BETAPACE TABS (View Betapace Tabs Review and Betapace Tabs Label ), AVALIDE (View Avalide Review and Avalide Label ), TRICOR (View Tricor Review and Tricor Label ), DIGITEK (View Digitek Review and Digitek Label ), POTASSIUM SUPPLEMENTS (View Potassium Supplements Review and Potassium Supplements Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ACTOS (View Actos Review and Actos Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5413626-3 | Rash
on Mar 20, 2007 Female patient from UNITED STATES , 67 years of age, weighting 220.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: rash (What is rash?). Glucovance dosage: . During the same period patient was treated with BYETTA ((0.25 Mg/ml)) (View Byetta Review and Byetta Label ), MOBIC (View Mobic Review and Mobic Label ).

5413624-X | Throat Irritation
on Mar 13, 2007 Female patient from UNITED STATES , 69 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: throat irritation. Glucovance dosage: 5mg/500mg, 2 Tablets In The Am And 2 Tablets In The Pm.. During the same period patient was treated with LOTREL (View Lotrel Review and Lotrel Label ), COREG (View Coreg Review and Coreg Label ), PLAVIX (View Plavix Review and Plavix Label ), DIGESTIVE ENZYMES (View Digestive Enzymes Review and Digestive Enzymes Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), MINERAL TAB (View Mineral Tab Review and Mineral Tab Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ).

5413623-8 | Headache, Nausea, Pharyngolaryngeal Pain, Sinus Congestion
Patient was taking Glucovance (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?), pharyngolaryngeal pain, sinus congestion on Mar 12, 2007 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 218.3 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ).

5413616-0 | Abdominal Distension, Anorexia, Blood Glucose Decreased, Blood Glucose Increased, Nausea
Adverse event was reported on Nov 30, 2006 by a Male patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, weight decreased, type 2 diabetes mellitus and. Location: UNITED STATES , 67 years of age, After Glucovance was administered, patient had the following side effects: abdominal distension, anorexia, blood glucose decreased, blood glucose increased, nausea (What is nausea?). During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), ACCURETIC (View Accuretic Review and Accuretic Label ).

5413615-9 | Chills, Diarrhoea, Eructation, Nausea, Weight Decreased
on Dec 08, 2006 Female patient from UNITED STATES , 63 years of age, weighting 213.8 lb, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: chills, diarrhoea, eructation, nausea (What is nausea?), weight decreased. Glucovance dosage: . During the same period patient was treated with BYETTA (Increased To 10mcg;bid,sc From 04-nov-2006 Ongoing) (View Byetta Review and Byetta Label ), AVANDAMET (View Avandamet Review and Avandamet Label ).

5413614-7 | Hypoglycaemia
on Nov 07, 2006 Female patient from UNITED STATES , 57 years of age, was treated with Glucovance (View Usage). Patient had the following side effects: hypoglycaemia. Glucovance dosage: .

5413613-5 | Hypoglycaemia, Weight Decreased
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: hypoglycaemia, weight decreased on Nov 02, 2006 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 224.9 lb, was diagnosed with diabetes mellitus management and. Glucovance dosage: .

5413611-1 | Asthenia, Blood Glucose Decreased, Decreased Appetite, Headache, Hunger, Hyperhidrosis, Nausea, Nervousness
Adverse event was reported on Sep 13, 2006 by a Female patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 53 years of age, weighting 196.2 lb, Patient experienced the following unwanted or unexpected effects: asthenia, blood glucose decreased, decreased appetite, headache (What is headache?), hunger, hyperhidrosis, nausea (What is nausea?), nervousness. During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ).

5413610-X | Blood Glucose Decreased, Nausea
on Sep 26, 2006 Female patient from UNITED STATES , 49 years of age, weighting 231.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: blood glucose decreased, nausea (What is nausea?). Glucovance dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AVANDIA (View Avandia Review and Avandia Label ), COZAAR (View Cozaar Review and Cozaar Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ).

5413609-3 | Incorrect Dose Administered
on Aug 28, 2006 Female patient from UNITED STATES , 48 years of age, weighting 165.3 lb, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: incorrect dose administered. Glucovance dosage: .

5413608-1 | Asthenia, Dizziness, Flatulence, Hypoglycaemia
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), flatulence, hypoglycaemia on Aug 14, 2006 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 165.3 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: Dosage Form = 5mg/500mg. During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5413605-6 | Incorrect Dose Administered, No Adverse Reaction
Adverse event was reported on Aug 03, 2006 by a Female patient taking Glucovance (View Usage) (Dosage: Dosage Form = 2.5 Mg/500 Mg) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 59 years of age, weighting 266.8 lb, Patient had the following side effects: incorrect dose administered, no adverse reaction. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), DETROL LA (View Detrol La Review and Detrol La Label ), ACTOS (View Actos Review and Actos Label ), COZAAR (View Cozaar Review and Cozaar Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ).

5413602-0 | Blood Glucose Increased, Malaise
on Jul 21, 2006 Female patient from UNITED STATES , 73 years of age, was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: blood glucose increased, malaise. Glucovance dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), LOTENSIN HCT (View Lotensin Hct Review and Lotensin Hct Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

5413349-0 | Lactic Acidosis, Productive Cough, Renal Failure Acute
on Aug 06, 2007 Female patient from GERMANY , 61 years of age, was diagnosed with tachycardia, hypertension, hypercholesterolaemia and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: lactic acidosis, productive cough, renal failure acute. Glucovance dosage: . During the same period patient was treated with DETENSIEL (View Detensiel Review and Detensiel Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5407974-0 | Lower Limb Fracture, Myocardial Infarction
Patient was taking Glucovance (View Usage). Patient had the following side effects: lower limb fracture, myocardial infarction on Jul 16, 2007 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with diabetes mellitus and. Glucovance dosage: 1.25 Mg / 250 Mg. During the same period patient was treated with AVALIDE TABL (View Avalide Tabl Review and Avalide Tabl Label ).

5406143-8 | Blood Glucose Decreased, Decreased Appetite, Loss Of Consciousness, Ovarian Cancer Metastatic, Weight Decreased
Adverse event was reported on Aug 02, 2007 by a Female patient taking Glucovance (View Usage) (Dosage: 1.5 Tablets Twice A Day Po (duration: Chronic } 6 Months)) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 72 years of age, After Glucovance was administered, patient had the following side effects: blood glucose decreased, decreased appetite, loss of consciousness, ovarian cancer metastatic, weight decreased. Patient was hospitalized.

5401939-0 | Lower Limb Fracture, Myocardial Infarction
on Jun 29, 2007 Male patient from UNITED STATES , 78 years of age, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: lower limb fracture, myocardial infarction. Glucovance dosage: 1.25/250 Mg Tablets. During the same period patient was treated with AVALIDE (300/12.5 Mg Tablets) (View Avalide Review and Avalide Label ). Patient was hospitalized.

5386688-X | Lower Limb Fracture, Myocardial Infarction, Stent Placement
on Jul 12, 2007 Male patient from UNITED STATES , 78 years of age, weighting 189.6 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: lower limb fracture, myocardial infarction, stent placement. Glucovance dosage: 1.25/250 Mg Tablets. During the same period patient was treated with AVALIDE (300/12.5 Mg Tablets) (View Avalide Review and Avalide Label ). Patient was hospitalized.

5373330-7 | Lower Limb Fracture, Myocardial Infarction
Patient was taking Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: lower limb fracture, myocardial infarction on Jun 25, 2007 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 189.6 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: 1.25/250 Mg Tablets. During the same period patient was treated with AVALIDE (300/12.5 Mg Tablets) (View Avalide Review and Avalide Label ). Patient was hospitalized.

5324018-X | Haemorrhage Intracranial, Multi-organ Failure, Syncope
Adverse event was reported on May 04, 2007 by a Female patient taking Glucovance (View Usage) (Dosage: ) . Location: AUSTRALIA , 60 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial, multi-organ failure, syncope. Patient was hospitalized.

5320614-4 | Bronchopneumonia, Cardiac Failure Congestive
on May 08, 2007 Female patient from UNITED STATES , 52 years of age, weighting 295.4 lb, was diagnosed with diabetes mellitus and was treated with Glucovance (View Usage). Patient had the following side effects: bronchopneumonia, cardiac failure congestive. Glucovance dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), ADVAIR DISKUS 100/50 (100/50) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PROCARDIA (View Procardia Review and Procardia Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

5288059-3 | Fall, Hypoglycaemia
on Mar 30, 2007 Female patient from GERMANY , 80 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, senile dementia and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: fall (What is fall?), hypoglycaemia. Glucovance dosage: . During the same period patient was treated with REMINYL (View Reminyl Review and Reminyl Label ). Patient was hospitalized.

5284792-8 | Bronchopneumonia, Cardiac Failure Congestive
Patient was taking Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia, cardiac failure congestive on Mar 30, 2007 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 295.4 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), ADVAIR DISKUS 100/50 (100/50) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PROCARDIA (View Procardia Review and Procardia Label ), SINGULAIR (View Singulair Review and Singulair Label ), ZANAFLEX (Dose-1 Mg Tablet-1/4 Tab Tid) (View Zanaflex Review and Zanaflex Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5275257-8 | Acute Myocardial Infarction
Adverse event was reported on Mar 22, 2007 by a Female patient taking Glucovance (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 63 years of age, Patient had the following side effects: acute myocardial infarction. During the same period patient was treated with STARLIX (View Starlix Review and Starlix Label ), EFFEXOR (Taken Every Other Day) (View Effexor Review and Effexor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), DETROL LA (View Detrol La Review and Detrol La Label ), NOVOLOG (View Novolog Review and Novolog Label ), MOBIC (View Mobic Review and Mobic Label ).

5263931-9 | Epistaxis, Thrombocytopenic Purpura
on Mar 02, 2007 Male patient from GERMANY , 83 years of age, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?) and was treated with Glucovance (View Usage). After Glucovance was administered, patient had the following side effects: epistaxis, thrombocytopenic purpura. Glucovance dosage: . During the same period patient was treated with INFLUENZA VACCINE (View Influenza Vaccine Review and Influenza Vaccine Label ), BRONCHO VAXOM (View Broncho-vaxom Review and Broncho-vaxom Label ), SINTROM (View Sintrom Review and Sintrom Label ), BELOC (View Beloc Review and Beloc Label ), TRIATEC (View Triatec Review and Triatec Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), MAGNESIUM CITRATE (View Magnesium Citrate Review and Magnesium Citrate Label ). Patient was hospitalized.

5248235-2 | Rash Pruritic
on Aug 30, 2006 Male patient from UNITED STATES , 57 years of age, weighting 169.8 lb, was diagnosed with diabetes mellitus management and was treated with Glucovance (View Usage). Patient experienced the following unwanted or unexpected effects: rash pruritic. Glucovance dosage: Glucovance 5mg/500mg 1 Or 2 Tablets Daily.. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ALLEGRA (View Allegra Review and Allegra Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), AZMACORT (View Azmacort Review and Azmacort Label ), FLONASE (View Flonase Review and Flonase Label ), GLUCOTROL XL (View Glucotrol Xl Review and Glucotrol Xl Label ).

5226227-7 |
Patient was taking Glucovance (View Usage). on Jan 23, 2007 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 249.1 lb, was diagnosed with diabetes mellitus and. Glucovance dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).